Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Tom R, De Meester"'
Autor:
Tom R. De Meester, Christy M. Dunst, Koji Tanaka, Hidekazu Kuramochi, Daniel S. Oh, D. Y. Yang, Steven R. De Meester, Peter V. Danenberg, Bethany J. Lehman, Jeffery A. Hagen, Kathleen D. Danenberg
Publikováno v:
International Journal of Oncology.
Thymidylate synthase (TS) is known to have polymorphisms in the 5' and 3' untranslated region (UTR). These polymorphisms have been reported to be associated with high TS expression and chemoresistance to 5-FU. The aim of this study was to examine the
Autor:
Hidekazu, Kuramochi, Koji, Tanaka, Daniel, Oh, Bethany J, Lehman, Christy M, Dunst, Dong Yun, Yang, Steven R, De Meester, Jeffery A, Hagen, Kathleen D, Danenberg, Tom R, De Meester, Peter V, Danenberg
Publikováno v:
International journal of oncology. 32(1)
Thymidylate synthase (TS) is known to have polymorphisms in the 5' and 3' untranslated region (UTR). These polymorphisms have been reported to be associated with high TS expression and chemoresistance to 5-FU. The aim of this study was to examine the
Autor:
Tom R. De Meester, Norman D. Anderson
Publikováno v:
The Journal of surgical research. 8(4)
HETEROLOGOUS antilymphocyte serum is the most potent immunosuppressive agent yet developed for promoting survival of skin and renal allografts in mice [6], rats [lo], dogs [5], and man [S]. Although little is known about its toxicity, clinical use of